Jiayu Jin
138 Yixueyuan Road
Xuhui, 200032, China
Xuhui, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.
Journal: Circulation
Published: May 26, 2026
Decoding the structure of GPR151 via NELiS.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 05, 2026
A BACH1 inhibitor ameliorates myocardial infarction and limb ischemia in mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 05, 2025
Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expression.
Journal: Journal of cellular physiology
Published: April 27, 2023
BACH1 regulates the differentiation of vascular smooth muscle cells from human embryonic stem cells via CARM1-mediated methylation of H3R17.
Journal: Cell reports
Published: April 23, 2023
Mitochondrial aspartate/glutamate carrier AGC1 regulates cardiac function via Drp1-mediated mitochondrial fission in doxorubicin-induced cardiomyopathy.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: February 06, 2023
BACH1 controls hepatic insulin signaling and glucose homeostasis in mice.
Journal: Nature communications
Published: January 18, 2023
BACH1 deficiency prevents neointima formation and maintains the differentiated phenotype of vascular smooth muscle cells by regulating chromatin accessibility.
Journal: Nucleic acids research
Published: October 10, 2022
Lipidome, central carbon metabolites, and sleep rhythm in coronary heart disease with nontraditional risks: An exploratory pilot study.
Journal: Heliyon
Published: August 01, 2022
Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.
Journal: Circulation research
Published: February 24, 2022
Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
Journal: Cardiovascular research
Published: January 16, 2022
SPTBN1 inhibits growth and epithelial-mesenchymal transition in breast cancer by downregulating miR-21.
Journal: European journal of pharmacology
Published: June 04, 2021
Last Updated: 09/26/2026